Shareholders of Sarda Proteins Limited approved a strategic rebranding and significant capital expansion during an Extra-Ordinary General Meeting (EGM) held on July 30, 2026. The key resolution saw members approve the change of the company’s name from Sarda Proteins Limited to Fresita Proteins Limited, subject to statutory and regulatory approvals. This move aligns with the company’s proposed future business activities and expansion plans, as reflected in the concurrent approval to alter the Main Object Clause of the Memorandum of Association.

The meeting, conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM) in compliance with Ministry of Corporate Affairs circulars and SEBI Listing Regulations, commenced at 11:00 A.M. (IST) and concluded at 11:21 A.M. (IST). Yagnik Arvindbhai Satasiya served as Chairperson of the meeting. CS Dharmik Solanki, Advisor to the Company, confirmed that the requisite quorum was present throughout the proceedings.

Beyond the name change, shareholders approved a substantial increase in the Authorized Share Capital from ₹13,00,00,000 (Rupees Thirteen Crore Only) to ₹1,00,00,00,000 (Rupees One Hundred Crore Only). This capital hike requires consequential alterations to Clause V of the Memorandum of Association. The company had already secured Name Availability Approval from the Central Registration Centre (CRC), Ministry of Corporate Affairs, for the proposed name "Fresita Proteins Limited". A certificate from the Statutory Chartered Accountant confirming compliance with Regulation 45 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 was also placed on record.

Board Appointments and Regularizations

The EGM addressed several critical governance matters, including the regularization and appointment of key board members:

Shirish Dhirajlal Savaliya, Managing Director of the company, signed the submission to the BSE Limited. The appointments aim to strengthen the board’s oversight capabilities as the company transitions under its new identity.

Auditor Appointments

Members also approved the appointment of Statutory Auditors to fill a casual vacancy. Additionally, the shareholders authorized the appointment of Statutory Auditors for a first term of five consecutive years, commencing from April 1, 2026, and ending on March 31, 2031. This long-term tenure provides continuity in financial oversight during the company’s restructuring phase.

What the Numbers Show

The decision to increase authorized share capital by nearly eight times — from ₹13 crore to ₹100 crore — signals Sarda Proteins’ intent to raise fresh equity or issue convertible instruments in the future without repeated shareholder approvals for minor increments. Combined with the name change to Fresita Proteins, these moves suggest a comprehensive strategic reset aimed at attracting new investors and expanding into new business verticals as outlined in the altered Main Object Clause.

Sarda Proteins Limited’s board has approved a proposal to change the company's name, subject to approval by the Central Registration Centre (CRC), Ministry of Corporate Affairs. The decision, taken during a meeting held on July 4, 2026, includes the consequent alteration of the Memorandum of Association and Articles of Association of the company. This strategic move requires regulatory consent before the new name can be adopted officially.

The board meeting commenced at 3:00 p.m. and concluded at 5:40 p.m. at the company's Registered Office. Managing Director Shirish Dhirajlal Savaliya oversaw the proceedings, which included this specific agenda item that was initially omitted in the earlier outcome filing submitted on July 4, 2026.

The revised disclosure was submitted to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company requested the exchange to record this additional agenda item alongside other approvals passed during the July 4 meeting.

Key Details of the Proposal

The alteration of the Memorandum of Association and Articles of Association is a standard procedural requirement when a company undergoes a name change. The final name will be determined based on the approval granted by the Central Registration Centre.